We are live on ! Find out more
CPX

Canaan Partners X Portfolio holdings

AUM $74.7M
1-Year Est. Return 151.56%
This Fund
S&P 500
This Quarter Est. Return
+11.56%
1 Year Est. Return
+151.56%
3 Year Est. Return
+55.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$63.8M
AUM Growth
+$5.96M
Cap. Flow
-$647K
Cap. Flow %
-1.01%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ITRM
Iterum Therapeutics
ITRM
+$351K
2
BGRY
Berkshire Grey, Inc. Class A Common Stock
BGRY
+$296K

Sector Composition

Rank Sector Weight
1 Healthcare 62.26%
2 Industrials 37.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IDYA icon
1
IDEAYA Biosciences
IDYA
$3.54B
$39.7M 62.26%
2,660,713
– –
BGRY
2
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$24.1M 37.74%
14,154,207
-148,316
-1% -$296K
ITRM
3
DELISTED
Iterum Therapeutics
ITRM
– –
-115,545
Closed -$351K

Similar funds

MIC
MU Investments Company Tokyo, Japan $74.7M AUM 21.79% 1-Year Est. Return
KCM
KLK Capital Management Los Angeles, California $74.7M AUM 13.54% 1-Year Est. Return
SV
Sturgeon Ventures London, United Kingdom $76M AUM 64.83% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return
BS
Bessemer Securities New York $72.2M AUM 28.36% 1-Year Est. Return
VCM
Vetamer Capital Management Menlo Park, California $72M AUM 31% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
JCG
John C. Goff $70.7M AUM 4.99% 1-Year Est. Return

Canaan Partners X's Q3 2022 Portfolio in Review

As of Q3 2022, Canaan Partners X held 3 positions worth $63.8M, up 10% from $57.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Canaan Partners X's Q3 2022 filing shows 1 reduced and 1 closed positions. The largest sale was Iterum Therapeutics, an estimated $351K.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 64% a quarter earlier, followed by Industrials.

  • Canaan Partners X's biggest Q3 2022 reduction was Berkshire Grey, Inc. Class A Common Stock, cutting an estimated $296K.
  • Canaan Partners X fully exited Iterum Therapeutics in Q3 2022, selling an estimated $351K.
  • Canaan Partners X's ten largest holdings make up 100% of its $63.8M portfolio in Q3 2022.
  • Canaan Partners X opened 0 new positions and closed 1 in Q3 2022.
  • Canaan Partners X's portfolio value rose 10% quarter-over-quarter to $63.8M.

Based on Canaan Partners X's 13F filing for Q3 2022, filed 31 Oct 2022.